Delivery of cancer therapeutics using nanotechnology

Eun Kyung Lim, Eunji Jang, Kwangyeol Lee, Seungjoo Haam, yongmin Huh

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Nanoparticles have been investigated as drug carriers, because they provide a great opportunity due to their advantageous features: (i) various formulations using organic/inorganic materials, (ii) easy modification of targeting molecules, drugs or other molecules on them, (iii) effective delivery to target sites, resulting in high therapeutic efficacy and (iv) controlling drug release by external/internal stimuli. Because of these features, therapeutic efficacy can be improved and unwanted side effects can be reduced. Theranostic nanoparticles have been developed by incorporating imaging agents in drug carriers as all-in-one system, which makes it possible to diagnose and treat cancer by monitoring drug delivery behavior simultaneously. Recently, stimuli-responsive, activatable nanomaterials are being applied that are capable of producing chemical or physical changes by external stimuli. By using these nanoparticles, multiple tasks can be carried out simultaneously, e.g., early and accurate diagnosis, efficient cataloguing of patient groups of personalized therapy and real-time monitoring of disease progress. In this paper, we describe various types of nanoparticles for drug delivery systems, as well as theranostic systems.

Original languageEnglish
Pages (from-to)294-317
Number of pages24
JournalPharmaceutics
Volume5
Issue number2
DOIs
Publication statusPublished - 2013 May 23

Fingerprint

Nanotechnology
Nanoparticles
Drug Carriers
Drug Delivery Systems
Neoplasms
Cataloging
Nanostructures
Drug Monitoring
Therapeutics
Group Psychotherapy
Early Diagnosis
Theranostic Nanomedicine

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science

Cite this

Lim, Eun Kyung ; Jang, Eunji ; Lee, Kwangyeol ; Haam, Seungjoo ; Huh, yongmin. / Delivery of cancer therapeutics using nanotechnology. In: Pharmaceutics. 2013 ; Vol. 5, No. 2. pp. 294-317.
@article{66ab40e114d04fcd95212510cd9c3d1b,
title = "Delivery of cancer therapeutics using nanotechnology",
abstract = "Nanoparticles have been investigated as drug carriers, because they provide a great opportunity due to their advantageous features: (i) various formulations using organic/inorganic materials, (ii) easy modification of targeting molecules, drugs or other molecules on them, (iii) effective delivery to target sites, resulting in high therapeutic efficacy and (iv) controlling drug release by external/internal stimuli. Because of these features, therapeutic efficacy can be improved and unwanted side effects can be reduced. Theranostic nanoparticles have been developed by incorporating imaging agents in drug carriers as all-in-one system, which makes it possible to diagnose and treat cancer by monitoring drug delivery behavior simultaneously. Recently, stimuli-responsive, activatable nanomaterials are being applied that are capable of producing chemical or physical changes by external stimuli. By using these nanoparticles, multiple tasks can be carried out simultaneously, e.g., early and accurate diagnosis, efficient cataloguing of patient groups of personalized therapy and real-time monitoring of disease progress. In this paper, we describe various types of nanoparticles for drug delivery systems, as well as theranostic systems.",
author = "Lim, {Eun Kyung} and Eunji Jang and Kwangyeol Lee and Seungjoo Haam and yongmin Huh",
year = "2013",
month = "5",
day = "23",
doi = "10.3390/pharmaceutics5020294",
language = "English",
volume = "5",
pages = "294--317",
journal = "Pharmaceutics",
issn = "1999-4923",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "2",

}

Delivery of cancer therapeutics using nanotechnology. / Lim, Eun Kyung; Jang, Eunji; Lee, Kwangyeol; Haam, Seungjoo; Huh, yongmin.

In: Pharmaceutics, Vol. 5, No. 2, 23.05.2013, p. 294-317.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Delivery of cancer therapeutics using nanotechnology

AU - Lim, Eun Kyung

AU - Jang, Eunji

AU - Lee, Kwangyeol

AU - Haam, Seungjoo

AU - Huh, yongmin

PY - 2013/5/23

Y1 - 2013/5/23

N2 - Nanoparticles have been investigated as drug carriers, because they provide a great opportunity due to their advantageous features: (i) various formulations using organic/inorganic materials, (ii) easy modification of targeting molecules, drugs or other molecules on them, (iii) effective delivery to target sites, resulting in high therapeutic efficacy and (iv) controlling drug release by external/internal stimuli. Because of these features, therapeutic efficacy can be improved and unwanted side effects can be reduced. Theranostic nanoparticles have been developed by incorporating imaging agents in drug carriers as all-in-one system, which makes it possible to diagnose and treat cancer by monitoring drug delivery behavior simultaneously. Recently, stimuli-responsive, activatable nanomaterials are being applied that are capable of producing chemical or physical changes by external stimuli. By using these nanoparticles, multiple tasks can be carried out simultaneously, e.g., early and accurate diagnosis, efficient cataloguing of patient groups of personalized therapy and real-time monitoring of disease progress. In this paper, we describe various types of nanoparticles for drug delivery systems, as well as theranostic systems.

AB - Nanoparticles have been investigated as drug carriers, because they provide a great opportunity due to their advantageous features: (i) various formulations using organic/inorganic materials, (ii) easy modification of targeting molecules, drugs or other molecules on them, (iii) effective delivery to target sites, resulting in high therapeutic efficacy and (iv) controlling drug release by external/internal stimuli. Because of these features, therapeutic efficacy can be improved and unwanted side effects can be reduced. Theranostic nanoparticles have been developed by incorporating imaging agents in drug carriers as all-in-one system, which makes it possible to diagnose and treat cancer by monitoring drug delivery behavior simultaneously. Recently, stimuli-responsive, activatable nanomaterials are being applied that are capable of producing chemical or physical changes by external stimuli. By using these nanoparticles, multiple tasks can be carried out simultaneously, e.g., early and accurate diagnosis, efficient cataloguing of patient groups of personalized therapy and real-time monitoring of disease progress. In this paper, we describe various types of nanoparticles for drug delivery systems, as well as theranostic systems.

UR - http://www.scopus.com/inward/record.url?scp=84877899798&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877899798&partnerID=8YFLogxK

U2 - 10.3390/pharmaceutics5020294

DO - 10.3390/pharmaceutics5020294

M3 - Article

VL - 5

SP - 294

EP - 317

JO - Pharmaceutics

JF - Pharmaceutics

SN - 1999-4923

IS - 2

ER -